TSANZ home

Results for "pulmonary function testing"

Home 5 Search query for: pulmonary function testing
Results for "pulmonary function testing"
VOLUME 5.03 – APRIL 2020

VOLUME 5.03 – APRIL 2020

Research Roundup:

April 2020

.

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. We currently have two invitations on offer – one for a study in Identifying barriers and facilitators to the implementation of best practice for pulmonary fibrosis in Australia, the other for participation in the ASCOT trial.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Respirology – Editor’s Choice 

Respirology Issue 25.4 April 2020

 

We won’t find what we don’t look for: Identifying barriers and enablers of chronic wet cough in Aboriginal children

Pamela Laird, Roz Walker, Mary Lane, Anne B. Chang and Andre Schultz

 

DOI: 10.1111/resp.13642

 

Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible?

Maria P. Arellano-Maric, Christine Hamm, Marieke L. Duiverman, Sarah Schwarz, Jens Callegari, Jan H. Storre, Claudia Schmoor, Marc Spielsmanns, Wolfgang Galetke and Wolfram Windisch

 

Principal investigator Maria Paola Arellano-Maric, MD (left) and senior investigator Prof. Dr. Wolfram Windisch (right)

DOI: 10.1111/resp.13704

ASCOT Trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

Invitation

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland

Professor of Physiotherapy, Monash University and Alfred Health

Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University

Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 5.03 – APRIL 2020

VOLUME 2.6 AUGUST 2017

Research Roundup:

August  2017

.
 

Welcome Message

Have you heard? Abstracts for TSANZSRS 2018 are now open. With this, our abstract-linked awards are also open. We are once again calling for applicants for the Ann Woolcock New Investigator Award, the JRS Travel Award, the Janet Elder Travel Award, and the Boehringer Ingelheim COPD Travel Award – which is now available to support travel to a range of international respiratory conferences (instead of only CHEST). Our ASM Travel awards are also open and we hope that everyone who is eligible takes up these opportunities.

More details on these awards are below and online.

Just over the horizon is APSR 2017 in Sydney.  A large number of abstracts have been received and late breaking abstracts will open on August 9th. Abstract acceptance will be notified in mid- August. If your abstract is accepted, you must be registered by September 28th. The developing program is now live. The theme is Lung Health in a Changing Worldand with a diverse and experienced group of international speakers attending, this should be a highly educational and engaging meeting. Early bird registration closes 3 September.

We have been able to partner with TEVA Pharmaceuticals and launch the TSANZ/TEVA Scholar Awards which cover registration costs for APSR 2017. These are open to Advanced Trainees in Respiratory and/or Sleep medicine and applications close on the 30th of August. Please spread the word – there are 30 scholarships available.

I would also like to update you on the consultation on A framework for NHMRC assessment and finding of clinical trials and cohort studies which we recently responded to. Thank you to those who assisted with this. Our response was in line with our commitment to increasing investment in respiratory research. While TSANZ was broadly supportive of the consultation recommendations, we advocated for inclusion of a policy review period, a moderation of process, opportunity to appeal and some consideration of a change in the length of the application given the necessity to include other supporting documentation for specific types of studies.

We will continue to work to increase funding for respiratory research and will adapt as the research landscape in Australia and New Zealand continues to change.

Lastly, there are a number of surveys at the end of this email and I urge you to participate in these and help where you can.

Enjoy the August edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

 

The following articles will take you to thelimbic.com

Work-related lung disease cases “tip of the iceberg”. A national register to record every case of work-related lung disease is one step closer following lobbying from the TSANZ and the Lung Foundation. Read More.

 + The rules for work-related lung disease compo are “unfair”. There are calls to expand the list of work-related lung disorders eligible for government compensation in NSW, amid concerns many with life-threatening conditions are missing out. Read More.

Oxygen saturation should be the 5th vital sign. A pulse oximeter should be as ubiquitous as a stethoscope, according to the British Thoracic Society’s new guidelines. Read More.

Non-invasive ventilation cuts COPD readmissions. Hard to treat patients with frequent COPD exacerbations can be kept out of hospital for longer when NIV is added to home oxygen. Read More.

Chronic breathlessness syndrome: a new name without shame.  We speak to Palliative medicine specialist Professor David Currow about his mission to get chronic breathlessness recognised as a distinct clinical entity. Read More.

Turf war stalling antibiotic stewardship. A rift between respiratory physicians and infectious diseases specialists could be stalling efforts to fight the growing problem of antimicrobial resistance in patients with respiratory infections, researchers claim. Read More.

Better bedside management of pleural effusions. Brisbane doctors have significantly improved the outcomes of patients with pleural effusions by giving registrars and trainees practical hands on training on the use of pleural ultrasound. Read More.

Open Awards

Thoracic Society Awards

TSANZ / TEVA Scholar Award

Encouraging all TSANZ Advanced Trainees Members to attend APSR 2017 for career development. Close 30 August 2017.

Abstract-linked awards are now open

Ann Woolcock New Investigator Award

The Ann Woolcock New Investigator Award is presented at the TSANZ Annual Scientific Meeting (ASM) to acknowledge excellence in the conduct and presentation of scientific research. 

This is a Travelling Fellowship of AUD$1500 plus expenses (return economy airfare, meeting registration and accommodation) to support the recipient to attend and present their original high-quality research to the next Annual Scientific Meeting of the Asia-Pacific Society of Respirology (APSR). Finalists (excluding the winning applicant) will receive a certificate of achievement and AUD $500.

This award furthers one of Professor Ann Woolcock’s goals of fostering research ties between the TSANZ and the APSR.

To apply for the Ann Woolcock New Investigator Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Ann Woolcock New Investigator Award eligibility criteria and application here coversheet please click here.

Boehringer Ingelheim COPD Travel Award

This travel award is designed to reward, encourage and provide international exposure for Advanced Trainees in Respiratory Medicine, junior Respiratory Physicians, post-doctoral respiratory healthcare professionals, and Respiratory Researchers whose work focuses on chronic obstructive pulmonary disease (COPD).

The award consists of up to AU$4000 to cover the recipient’s expenses (return airfare, registration, accommodation, living expenses) to attend and present an abstract at a relevant international respiratory conference, including: the American College of Chest Physicians, the European Respiratory Society, Asian Pacific Society of Respirology , or the American Thoracic Society.

To view the Boehringer Ingelheim COPD Travel Award eligibility criteria and application coversheet please click here.

Janet Elder International Travel Award

These awards will be made to three respiratory scientists or clinicians on the basis of scientific merit of their submitted abstract to the 2018 TSANZ Annual Scientific Meeting (ASM) to support their professional development in respiratory research. There will be two awards for early career researchers and one award for a mid-career researcher.

Each award consists of AUD$2500 to contribute to expenses to attend and present an abstract at an international scientific meeting of the recipient’s choice within the following year. 

These awards are made in the memory of Dr Janet Elder, one of the pioneers of respiratory medicine in Western Australia.

To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Janet Elder International Travel Award eligibility criteria and application coversheet please click here.

Japanese Respiratory Society (JRS) Early Career Development

This Early Career Development Award is designed to reward, encourage and provide international exposure to promising recent advanced trainees/higher degree graduates. 

The award will cover the recipient’s expenses (return economy airfare to Japan, registration, accommodation, living expenses) to attend and present at the Annual Scientific Meeting of the Japanese Respiratory Society in the following year. This award is fully provided by the Japanese Respiratory Society.

To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the Japanese Respiratory Society (JRS) Early Career Development eligibility criteria and application coversheet please click here.

TSANZ Travel Grants to 2018 ASM

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the Annual Scientific Meeting (ASM) through presentation of their work and active participation in the meeting. They are awarded to eligible applicants planning to pursue a career in respiratory medicine or related fields, based on the quality of the abstract submitted for presentation to the ASM.

To be eligible for the TSANZ Travel Grants to 2018 ASM Award, you must submit an accompanying form of certification (attach here) completed by your supervisor/head of department using the upload functionality in the online abstract submission form. To apply for the  Award, you must complete the application coversheet using the upload functionality in the online abstract submission portal. To view the TSANZ Travel Grants to 2018 ASM eligibility criteria and application coversheet please click here.

Lung Foundation Australia Awards

Lung Foundation Australia and Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Research Fellowship – 2018/2019

Valued at $80,000 per year/ one or two years

Lung Foundation Australia / Boehringer Ingelheim COPD Fellowship supports research to improve the diagnosis and management of Chronic Obstructive Pulmonary Disease in Australia. Specifically, the proposed research must be aimed at developing and/or delivering optimal care to people with COPD.

Relevant domains of research inquiry range from evaluation of population screening initiatives; interventions to improve diagnostic accuracy within primary care; through to issues of management in the context of a clinician-patient interaction to system level issues to do with the organisation, financing and performance of the health system, including COPD management of indigenous and ethnic minorities within Australia.

Lung Foundation Australia invites applications from medical and scientific graduates who will be a resident in Australia throughout the period of the research program. The Fellowship is available as either a one or two year award, with a value of $A80,000 per annum. The funds are to cover the salary (including on-costs) for the successful research fellow and for no other purpose.

Apply now


NEW Lung Foundation Australia and the Better Breathing Foundation Allied Health PhD Scholarship in Chronic Lung Disease – 2018/2021

Valued at $20,000 per year/four years: $40,000 per year/four years with matched funds

This Scholarship is made possible via a collaborative partnership with Lung Foundation Australia and the Better Breathing Foundation. The LFA/BBF Allied Health PhD Scholarship aims to support allied health professionals to undertake research into chronic lung disease. Relevant domains of research include any form of clinical, population, laboratory or genetics research.

Students with an allied health background wishing to undertake a PhD in chronic lung disease are invited to submit an application. This PhD Scholarship is aimed at a researcher who is commencing a higher degree and interested in improving outcomes for patients living with a chronic lung disease.

Lung Foundation Australia/Better Breathing Foundation will be allocating a set amount of funds of $20,000 per year over a four year period (total funding: $80,000) for the PhD Scholarship, with matching funds to be provided by the University.

Apply now


Lung Foundation Australia / Ivan Cash Research Grant-in-Aid for Idiopathic Pulmonary Fibrosis Research 2018

Valued at $5,000

The Ivan Cash Research Grant-in-Aid’s creation was made possible by a bequest from Mr Ivan Cash, who sadly died from his idiopathic pulmonary fibrosis (IPF) in 2008. Lung Foundation Australia invites applications for the Ivan Cash Research Grant-in-Aid valued at $5,000. This IPF Research Award is open to any individual health care professional or scientist, who will be required to collaborate with the Australian IPF Registry management committee to undertake and publish a specific focused analysis of part of the collected dataset of the Australian IPF Registry. The Australian IPF Registry management committee will provide support to the successful applicant to enable the completion of the required research.

Apply now


Lung Foundation Australia / Lizotte Family Research Award for Interstitial Pulmonary Fibrosis Research 2018

Valued at $5,000

Lung Foundation Australia invites applications for the Lizotte Family Research Award valued at $5,000 – to assist research in interstitial pulmonary fibrosis (IPF). This Research Award is open to any individual health care professional or group of health care professionals who are able to demonstrate an interest in IPF, including respiratory physicians, histopathologists, radiologists, researchers, registrars, trainees, nursing and allied health staff.

The funds may be used as a contribution towards IPF related research or pilot projects, or to fund travel or education with respect to increasing knowledge about IPF.

Apply now


Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research 2018

Valued at $5,000

Lung Foundation Australia invites applications for the Ludwig Engel Grant-in-Aid valued at $5,000 – to assist research in respiratory physiology. For the purpose of this Grant-in-Aid, Physiological Research is the use of any methodologies directed towards the elucidation of organ function and its understanding in a precise, quantitative manner.

The funds may be used as a contribution towards equipment, personnel or other running costs incurred in the conduct of research projects. The Grant-in-Aid is not to be used to fund conference travel or conference attendance.

Apply Now


Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to key health professionals in Australia whose work is focused on improving outcomes for patients living with COPD.

Apply now


Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

How to participate

Follow the links above to access each award application form and download the information sheet.

More Information

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Lung Foundation Australia contact details
Glenda Colburn | Phone 07 3251 3600 | Email: glenda@lungfoundation.com.au

Watch this space for more award announcements…

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late August and December, 2017:

Westpac Bicentennial Foundation Research Fellowship – closes 31/08/17
The Westpac Research Fellowship supports outstanding early career researchers whose ground-breaking work has the potential to make a difference in one of the Foundation’s focus areas: Technology and innovation, Strengthening Australia-Asia ties, and Enabling positive social change.

Westpac Bicentennial Foundation Social Change Fellowship – closes mid-August/2017
The Westpac Social Change Fellowship is an opportunity to invest in your capability, knowledge and networks with a view to helping you bring to life your innovative initiative for positive social change in Australia.

Rebecca L Cooper Medical Research Foundation – Medical Research Grants – closes 01/09/17
Advancing, promoting and encouraging medical research into Brain Sciences (psychiatry and neurology), Endocrinology and Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, Vision Sciences. Funding is primarily granted for the purchase of equipment, but may be used for other tangibles (e.g. therapeutic or imaging markers, software etc.). Funding requests for salaries/wages are not strongly supported, but will be considered by the directors.

The Prince Charles Hospital Foundation Emerging Researcher Grant – closes 01/09/17
The Emerging Researcher Grant is aimed at providing New Investigators who have previously received and successfully completed a New Investigator grant from TPCHF the opportunity to further develop their skills, experience and build the research capacity of TPCH The priority areas are: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

Harkness Fellowships in Health Care Policy and Practice 2018-2019 – closes 05/09/17
For mid-career professionals (academic researchers, government policymakers, clinicians, managers, and journalists) from Australia, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom, to spend up to 12 months in the US conducting a policy-oriented research study, working with leading US health policy experts, and gaining an in-depth knowledge of the US and other health care systems.

Tasmania Community Fund – small grants close 06/09/17, large grants close 27/09/17
To fund community organisations that make a difference by enhancing well-being and improving the social, environmental and economic outcomes for the Tasmanian community. Five category areas: children and young people; community participation and recreation; community well-being and life skills; connecting communities; culture, arts and heritage. Large grants are for applications for large infrastructure, asset and/or equipment.

Future Research Leader Fellowships – EOI closes 15/09/17
5 year full time Fellowships to provide salary and project support to encourage high calibre interstate and international emerging researchers to develop a program of work that support the activities that are being undertaken by the Translational Cancer Research Centres (TCRCs) in NSW. Applications must be in the area of implementation research and, more specifically, should address how research findings from the TCRCs can be taken up into routine cancer care.

CASS Medicine/Science Grants – 15/09/17
Research and development projects in science and/or medicine. Preference is given to proof of concept project applications. CASS will only accept applications from applicants employed by specific Victorian research centres.

Shepherd Foundation – closes 15/09/17
The Shepherd Foundation Trust welcomes grant applications from Victorian health professionals or research teams working in clinical, medical or scientific fields.  Grants are provided for research projects in all aspects of preventive medicine and/or occupational medicine. For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Conquer Cancer Career Development Award – closes 21/09/17
Provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Submissions in all oncology sub specialties are welcome.

Financial Markets Foundation for Children – closes 30/09/17
Research programs designed to improve the health, welfare and wellbeing of Australian children. Preference will be given to projects focussed on children aged 14 years and under, although the Foundation will consider projects relating to children up to 18 years of age.

Cancer Research Institute CRI Irvington Postdoctoral Fellowship Program – closes 01/10/17
Supports qualified young scientists at leading universities and research centres around the world who wish to receive training in cancer immunology. An eligible project must be immunology with direct relevance to solving the cancer problem.

World Cancer Research Fund International – closes 06/10/17
To fund research studies exploring the link between diet, nutrition, body composition, physical activity, and cancer prevention and survival. There are 2 types of grants: Investigator Initiated Grants for Principal Investigators; and Pilot Grants to be used as start-up funds for pilot research. Two main themes: identifying the mechanisms that underpin the effects of diet, nutrition and physical activity on cancer; addressing the host factors that influence an individual’s susceptibility to cancer development or progression.

The Bonser Family Research Grant and Mi-tec Publishing Medical Research Grant – closes 21/10/17
Cancer Council Tasmania calling for research relating to the reduction of the incidence and impact of cancer on individuals and the community. It includes every aspect of care, from prevention and early detection that leads to a better outcome, treatment and supportive care. The priority area is cancer control.

Rolling Grants

Auswide Community Grants Scheme –  grants under $5 000 close 30/09/17, grants over $10 000 close 21/10/17, grants over$ 5 000 close 01/12/17.
Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

John Templeton Foundation
Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

allport bequest – closes 30/06 and 31/12 yearly
Must benefit citizens of Hobart. Organisation must be charitable or the project must be for charitable purposes.

 

Respirology

New from ANZSRS

ANZSRS’s Spirometry Training Courses Position Statement
Maureen P. Swanney, Christopher A. O’Dea, Emily R. Ingram, Leanne T. Rodwell, Brigitte M. Borg, for the ANZSRS Spirometry Training Course Working Group

Respirology Issue 22.6

Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapores perspective on a global model.

HAI V. NGUYEN , SAIDEEP BOSE, SHWETA MITAL, ANTHONY CHAU ANG YII, SHIN YUH ANG, SEAN SHAO WEI LAM, DEVANAND ANANTHAM, ERIC FINKELSTEIN and MARIKO SIYUE KOH

DOI: 10.1111/resp.13027

 

Cost-effectiveness acceptability curve of bronchial thermoplasty with and without optimized asthma therapy

Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions

JONATHAN A. GALLI , ALOKNATH PANDYA, MICHELLE VEGA-OLIVO, CHANDRA DASS, HUAQING ZHAO and GERARD J. CRINER

DOI: 10.1111/resp.13024

Research team at the Temple Lung Center in Philadelphia, USA. From left to right: Huaqing Zhao, Jonathan Galli, Chandra Dass, Michelle Olivo-Vega and Gerard Criner.  Not included in the photo is Aloknath Pandya.

Research Project and Survey Requests

Inhaler Overhaul in Sight for Mild Asthma  –  recruitment closing soon

Friends and family with mild asthma could soon have a new treatment at their fingertips if results of the Novel Start Study show the condition can be well managed without daily medication.

People with apparently mild asthma make up 20 per cent of adults who die of asthma, and a third of people who need emergency asthma treatment,” says asthma specialist Professor Helen Reddel, who is heading the study in Australia.

Asthma experts in New Zealand and at the Woolcock Institute of Medical Research in Sydney and John Hunter Hospital in Newcastle are testing a new combination puffer treatment that could reduce asthma flare-ups and change the way mild asthma is treated worldwide.

Anyone who is using only Ventolin (or similar) for their asthma can volunteer – recruitment closes soon – by the end of August 2017.

Woolcock Institute, Sydney, Australia
Call: 02 9114 0444 or email gloria.foxley@sydney.edu.au

Hunter Medical Research Institute, Newcastle, Australia
Call: 02 4042 0532 or email joanne.howes@newcastle.edu.au

Medical Research Institute of NZ – Wellington, NZ
Call: 04 805 0147 or email irene.braithwaite@mrinz.ac.nz

 

 

‘Usual’ antenatal asthma management

Dear Colleague,

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study. All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 

Barriers and Facilitators to Optimal use of Acute Oxygen Therapy in Adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE.

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE.

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

ATS Conference Review

Please CLICK HERE to view the publication by Research Review on the recent American Thoracic Society (ATS) conference.

TSANZ Recruiting Now

Administrative Officer (up to $60,000 + super)

  • Excellent working conditions
  • Access to salary sacrifice and other benefits
  • Annual leave loading
  • Flexible working conditions, friendly team and great working environment

Function: This position is responsible for providing administrative support

Reports to: Chief Executive Officer (CEO)           

Salary: $50,000-$60,000 (dependent on experience)

Permanent full time

ROLE PURPOSE: This position is responsible for providing administrative support to the New Zealand Branch, assisting the CEO in managing the activities of the office and supporting the laboratory accreditation program.

Job Accountabilities:

  1. Document management is maintained for all TSANZ controlled documents
  2. Provides a high level of administrative support to the TSANZ Board and CEO
  3. Executive officer assistance to NZ branch to support compliance with NZ legislation and constitution
  4. Undertake administrative support to the laboratory accreditation program:
  • Provide administrative support to subcommittees
  • Regular liaison with the Laboratory Accreditation Coordinator and Subcommittee Chairs to ensure effective overall management of the laboratory accreditation program
  • Check the accreditation applications against TSANZ Laboratory Manual and communicate it back to the laboratories for any major inaccuracy
  • Organise laboratory site visit including date, agenda, travel and accommodation
  • Liaise with assessor panels and laboratories on an ongoing basis to make sure they have the information and support to provide the appropriate application and  assessment
  • Ensure reports/responses from assessor panels and laboratories are received on time, and provided to the CEO and Chair LAC for moderation
  • Maintain accreditation documents including the manual, forms and other templates
  • Maintain accreditation files of each laboratory to reflect best practice in document management
  • Maintain the accredited laboratory information on the TSANZ website
  • Preparation of reports and correspondence     

KEY SELECTION CRITERIA – please address the following in your application:

  • Experience in working in an office environment
  • Must have the ability to communicate accurately and clearly both orally and in writing
  • Pleasant telephone manner
  • Able to think on feet when dealing with callers
  • Customer service oriented with a “can do” approach to work
  • Microsoft Office expertise
  • A team player who is able to work effectively as part of a small productive team and as a self-motivated individual
  • Superior organisational skills, attention to detail and problem solving skills
  • Excellent people skills
  • Experience working in a quality assured environment is advantageous

HOW TO APPLY:

Click apply or send your resume to Tanya.Buchanan@thoracic.org.au by Friday 11th August 2017

Please clearly indicate your relevant experiences and skills to this role.

Position Description: https://www.thoracic.org.au/documents/item/1044

OVERVIEW OF TSANZ: The Thoracic Society of Australia and New Zealand Ltd (TSANZ) is a company limited by guarantee and a health promotion charity (HPC) established to improve the knowledge and understanding of lung disease, to prevent respiratory illness through research and health promotion, and improving health care for people with respiratory disorders.

For details concerning this role, please contact Tanya Buchanan, Phone : 0292226205
Email : tanya.buchanan@thoracic.org.au

You must have the right to live and work in this location to apply for this job.

 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.03 – APRIL 2020

VOLUME 2.5 JUNE 2017

Research Roundup:

June  2017

.
 

Welcome Message

At the end of last month the NHMRC announced the grant program restructure. These changes will consolidate support for investigators and boost funding for ideas. Grants will also be larger with the aim to achieve greater gains and reduce the burden of writing grants. I have recently returned from the American Thoracic Society Conference and saw these changes in funding models are being reflected internationally, with major changes in NIH funding models similar to what we are seeing with the NHMRC.

I would like to draw your attention to the Public consultation on “A Framework for NHMRC Assessment and Funding of Clinical Trials and Cohort Studieswhich is now open on the NHMRC Public Consultations Portal. The consultation paper is available here. TSANZ will submit a response to this consultation on behalf of the society and you are encouraged to send in your opinion to the office to ensure our response is representative of our membership. Please let us know your opinion on this by the 29th of June by responding to TSANZoffice@thoracic.org.au

For now, I will leave you with the many awards we are hosting, and the long list of direct-to-researcher funds which have been identified below, through  the Lungs for Life project. Respirology has also supplied us with their Editor’s Choice articles, again featuring our members.

Enjoy the June edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

The following articles will take you to thelimbic.com

Better bedside management of pleural effusions. Brisbane doctors have significantly improved the outcomes of patients with pleural effusions by giving registrars and trainees practical hands on training on the use of pleural ultrasound. Read More.

Integrating palliative and respiratory care is possible. Patients with COPD and their doctors are reluctant to consider palliative care however a new model of care might help with that. Read More.

Oxygen saturation should be the 5th vital sign. A pulse oximeter should be as ubiquitous as a stethoscope, according to the British Thoracic Society’s new guidelines. Read More.

Non-invasive ventilation cuts COPD readmissions. Hard to treat patients with frequent COPD exacerbations can be kept out of hospital for longer when NIV is added to home oxygen. Read More.

No need to wait for Europe on severe eosinophilic asthma. The European respiratory community is working towards consensus on the diagnosis and management of severe eosinophilic asthma but there’s no need to wait for them, according to an Australian expert. Read More.

Fake stone a lung hazard. Scores of people who work with a product hailed as a cheap alternative to marble and granite could be at risk of developing a debilitating lung disease, Australian respiratory physicians warn. Read More.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM Travel Grant – Supported by GSK  Deadline extended – 28 July 2017

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the NZ Annual Scientific Meeting through presentation of their work and active participation in the meeting.

There will be seven awards of $NZ500 to support the career development of TSANZ nurses and allied health professionals.

Vertex Paediatric Cystic Fibrosis Clinical Fellowship

The TSANZ Vertex Cystic Fibrosis Paediatric Clinical Fellowship supports an articulated training program for advanced trainees who are currently, or who wish to sub-specialize in Paediatric Respiratory Medicine, specifically to conduct the research, diagnosis and management of cystic fibrosis in Australia and New Zealand.

This is a unique opportunity to secure a fellowship that supports clinic based training in a Paediatric specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Adult Cystic Fibrosis Fellowship

The TSANZ Vertex Adult Cystic Fibrosis Fellowship will support a health practitioner or research scientist working in respiratory medicine who wishes to undertake research into adult cystic fibrosis, accompanied with professional development in adult cystic fibrosis in Australia or New Zealand.

This is a unique opportunity to secure a fellowship that supports either research and/or clinic based training / professional development in the adult cystic fibrosis specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Cystic Fibrosis Research Awards

To foster ongoing original cystic fibrosis research and its communication internationally.

The winners of the awards (2) will receive an award up to the value of AUD$7500 each to support their economy class travel, registration and accommodation to present their research at the European Cystic Fibrosis Society Annual Meeting or the North American Cystic Fibrosis Conference.

Lungs for Life Awards

Lungs for Life Research Awards – Closing soon – 30 June 2017

This Research Award aims to provide seed funding for critical and impactful areas of respiratory research. Preference will be given to research proposals in the priorities areas of early lung development, infection, and lung cancer. Three research proposals will be funded.

The Research Award value will total $40,000. Funds will be offered as $20,000 from Lungs for Life and must be matched with equal or greater funding from the applicant’s institution.

Lung Foundation Australia Awards

Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

Cystic Fibrosis Australia Awards

Abbie Fennessy Memorial Fellowship (Sponsored by Technipro-Pulmomed Pty Ltd). More Information [PDF] | Application form [word doc]

The aim of the Fellowship is to improve the knowledge and skills of Allied Health & Nursing professionals working in Cystic Fibrosis care to benefit those who have Cystic Fibrosis. The award provides up to $5000 to support education, training, academic purposes, and/or medical research, activities that improve the quality of medicine and the improvement of Cystic Fibrosis patient outcomes.  The Fellowship is open to Allied Health & Nursing professionals involved in the treatment or care of people with Cystic Fibrosis in Australia.

Watch this space for more award announcements…

icare dust diseases care Scholarships and Fellowships

 

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late June and September, 2017:

Wellcome Trust Pathfinder Awards – closes 20/06/17
The diagnosis, prevention and treatment of orphan and neglected diseases that present an unmet medical need. Seeking to fund pilot studies to develop assets and de-risk future development.

Australian Cancer Research Foundation (ACRF) Cancer Research Grants – closes 23/06/17
Seeks to support all aspects of cancer research and control including but not limited to: cell or molecular biology, epidemiology, early detection, prevention and drug development. Focused on seed funding; primarily providing capital grants for major equipment, and the establishment of capital works and facilities. Collaborative projects between institutions are encouraged.

John T Reid Charitable Trusts – opens 06/07/17 and “closes once a volume of applications have been received”.
The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

The Sir Robert Menzies Memorial Research Scholarship in the Allied Health Sciences – closes 30/06/17
The purpose of the scholarship is to try to improve the health of Australians by supporting an outstanding applicant from one of the non‐medical allied health disciplines, or from an applicant who is working directly in applied clinical research.

The John Burge Trust – closes 30/06/17
The John Burge Trust was established by the late John Burge to assist people with tuberculosis and support work towards the prevention and cure of the disease. This can include: educational programs for health workers; aid and help for tuberculosis sufferers and who by reason of the disease are disabled; medication; research.

Shepherd Foundation Research Grants – closes 01/07/17 and 15/09/17
For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

GlaxoSmithKline Australia Award for Research Excellence – closes 10/07/17
Recognition for an outstanding researcher with a demonstrated track record of significant work in human medical health, and for whom the award will facilitate career development and further achievements.

2017 Research Australia Health and Medical Research Awards – closes 17/07/17
Research Australia’s annual awards recognise significant contributions to health and medical research.

The Alan Westcare Project Grant – closes 31/07/17
The Alan King Westcare Project Grant is a 12 month $50,000 grant to available to laboratory, clinical and epidemiological research into the cause, diagnosis, prevention and treatment of respiratory infections such as tuberculosis.

CSL Centenary Fellowships 2017 – closes 31/07/17
To foster excellence in Australian medical research by supporting mid-career Australian scientists to pursue world class medical research. The fellowship provides for a full-time salary (generally equivalent to a Senior Research Fellow C1 level) plus research costs and/or a post-doctoral research assistant. The breakdown is determined by the Fellow, in conjunction with the employing institution at the commencement of the Fellowship. The fellowships are primarily awarded for discovery and translational research with a focus on rare and serious diseases, immunology, and inflammation. However, those who meet the eligibility are strongly encouraged to submit an application for their medical research project.

Centenary Institute Medical Innovation Award 2017 – closes 31/07/17
The Prize focuses on creativity – the essential ingredient in all human endeavour, whether in science, art or marketing. It will be presented to the biomedical research scientist based in Australia who demonstrates the greatest creativity in their scientific approach in a given year. Valued at $36,000.

Westpac Bicentennial Foundation Research Fellowship – closes 31/08/17
The Westpac Research Fellowship supports outstanding early career researchers whose ground-breaking work has the potential to make a difference in one of the Foundation’s focus areas: Technology and innovation, Strengthening Australia-Asia ties, and Enabling positive social change.

Westpac Bicentennial Foundation Social Change Fellowship – closes mid-August/2017
The Westpac Social Change Fellowship is an opportunity to invest in your capability, knowledge and networks with a view to helping you bring to life your innovative initiative for positive social change in Australia.

Rebecca L Cooper Medical Research Foundation – Medical Research Grants – closes 01/09/17
Advancing, promoting and encouraging medical research into Brain Sciences (psychiatry and neurology), Endocrinology and Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, Vision Sciences. Funding is primarily granted for the purchase of equipment, but may be used for other tangibles (e.g. therapeutic or imaging markers, software etc.). Funding requests for salaries/wages are not strongly supported, but will be considered by the directors.

The Prince Charles Hospital Foundation Emerging Researcher Grant – closes 01/09/17
The Emerging Researcher Grant is aimed at providing New Investigators who have previously received and successfully completed a New Investigator grant from TPCHF the opportunity to further develop their skills, experience and build the research capacity of TPCH The priority areas are: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

Harkness Fellowships in Health Care Policy and Practice 2018-2019 – closes 05/09/17
For mid-career professionals (academic researchers, government policymakers, clinicians, managers, and journalists) from Australia, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom, to spend up to 12 months in the US conducting a policy-oriented research study, working with leading US health policy experts, and gaining an in-depth knowledge of the US and other health care systems.

Future Research Leader Fellowships – EOI closes 15/09/17
5 year full time Fellowships to provide salary and project support to encourage high calibre interstate and international emerging researchers to develop a program of work that support the activities that are being undertaken by the Translational Cancer Research Centres (TCRCs) in NSW. Applications must be in the area of implementation research and, more specifically, should address how research findings from the TCRCs can be taken up into routine cancer care.

Conquer Cancer Career Development Award – closes 21/09/17
Provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Submissions in all oncology sub specialties are welcome.

Financial Markets Foundation for Children – closes 30/09/17
Research programs designed to improve the health, welfare and wellbeing of Australian children. Preference will be given to projects focussed on children aged 14 years and under, although the Foundation will consider projects relating to children up to 18 years of age.

Cancer Research Institute CRI Irvington Postdoctoral Fellowship Program – closes 01/10/17
Supports qualified young scientists at leading universities and research centres around the world who wish to receive training in cancer immunology. An eligible project must be immunology with direct relevance to solving the cancer problem.

Rolling Grants

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

 

PhD Scholarships

PhD Scholarship opportunity available at the University of Newcastle: Maternal and early life nutritional status and respiratory health of the offspring.

Please see flyer for more information [PDF]

Applications close 31st July, 2017.

Respirology

Respirology Issue 22.5

Airflow limitation severity and post-operative pulmonary complications following extra-pulmonary surgery in COPD patients.

Beomsu Shin, Hyun Lee, Danbee Kang, Byeong-Ho Jeong, Hyung Koo Kang, Hae Ri Chon, Won-Jung Koh, Man Pyo Chung, Eliseo Guallar, Juhee Cho and Hye Yun Park

DOI: 10.1111/resp.12988

 

From left to right: Juhee Cho, Hye Yun Park, Hyun Lee, Danbee Kang and Beomsu Shin from South Korea

 

Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry

IAN N. Glaspole SALLY A. Chapman, WENDY A. Cooper, SAMANTHA J. Ellis, NICOLE S. Goh, PETER M. Hopkins, SACHA Macansh, ANNABELLE Mahar, YUBEN P. Moodley, ELDHO Paul, PAUL N. Reynolds, E.HAYDN. Walters, CHRISTOPHER J. Zappala  and TAMERA J. Corte

DOI: 10.1111/resp.12989

 

National spread of participants of the Australian Idiopathic Pulmonary Fibrosis Registry recruited from all states and territories in Australia.

Research Project and Survey Requests

‘Usual’ antenatal asthma management

Dear Colleague,

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study. All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 

Barriers and Facilitators to Optimal use of Acute Oxygen Therapy in Adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE.

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE.

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.03 – APRIL 2020

VOLUME 2.4 MAY 2017

Research Roundup:

May  2017

.
 

Welcome Message

This edition of the Research Roundup is full of open awards which are quite varied in who and what they support. However, I would like to highlight the Lungs for Life Research Awards, which are seed grants purely to support respiratory research. We want these grants to support the generation of data which can be used for larger projects in the future. Research proposals for the Lungs for Life Research Awards may come from any area of respiratory medicine, however preference will be given to research into early lung development, lung cancer, and respiratory infectious disease, as they are the current priorities of this strategic project. These awards are an exciting opportunity and not to be missed.

For those of you heading off to the Congress of the American Thoracic Society, please make sure you drop into the TSANZ stand. Our CEO, Tanya will be on site and will welcome any visitors! I will also be there and hope to see you there enjoying the latest in respiratory research.

Enjoy the May edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

The following articles will take you to thelimbic.com

Final thunderstorm asthma report needs to be broader. The final report on the emergency response to the unprecedented thunderstorm asthma event that affected thousands of people in Victoria last year demonstrates commitment to preventing similar events but needs to be broader, an expert says. Read More.

Integrity of large international trials in question. Large international randomised controlled trials, the cornerstone of modern medicine, are in big trouble. Read More.

Euthanasia debate killing the bigger picture. The persistent media and political focus on euthanasia has skewed the debate about end of life issues and diverted attention away from adequately resourcing palliative care services that would benefit many more people, an expert says. Read More.

Steroids risky in the short-term. A BMJ study that found an up to five-fold increased risk in fractures, blood clots and sepsis with short-term use of oral steroids is a wakeup call for clinicians to consider whether their use is evidence-based for the problem they’re treating. Read More.

Death by air pollution. Long-term exposure to fine air particles caused 4.2 million deaths and over 103 million lost years of healthy life in 2015, a global report of pollution levels over a quarter of a century shows. Read More.

Australian study most influential respiratory paper. The study has been highlighted by the American College of Physicians as one of the most influential studies in respiratory medicine to be published last year. Read More.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM Travel Grant – Supported by GSK

These travel awards are made available to encourage eligible TSANZ members to attend and enrich the NZ Annual Scientific Meeting through presentation of their work and active participation in the meeting.

There will be seven awards of $NZ500 to support the career development of TSANZ nurses and allied health professionals.

Vertex Paediatric Cystic Fibrosis Clinical Fellowship

The TSANZ Vertex Cystic Fibrosis Paediatric Clinical Fellowship supports an articulated training program for advanced trainees who are currently, or who wish to sub-specialize in Paediatric Respiratory Medicine, specifically to conduct the research, diagnosis and management of cystic fibrosis in Australia and New Zealand.

This is a unique opportunity to secure a fellowship that supports clinic based training in a Paediatric specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Adult Cystic Fibrosis Fellowship

The TSANZ Vertex Adult Cystic Fibrosis Fellowship will support a health practitioner or research scientist working in respiratory medicine who wishes to undertake research into adult cystic fibrosis, accompanied with professional development in adult cystic fibrosis in Australia or New Zealand.

This is a unique opportunity to secure a fellowship that supports either research and/or clinic based training / professional development in the adult cystic fibrosis specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Cystic Fibrosis Research Awards

To foster ongoing original cystic fibrosis research and its communication internationally.

The winners of the awards (2) will receive an award up to the value of AUD$7500 each to support their economy class travel, registration and accommodation to present their research at the European Cystic Fibrosis Society Annual Meeting or the North American Cystic Fibrosis Conference.

Lungs for Life Awards

Lungs for Life Research Awards

This Research Award aims to provide seed funding for critical and impactful areas of respiratory research. Preference will be given to research proposals in the priorities areas of early lung development, infection, and lung cancer. Three research proposals will be funded.

The Research Award value will total $40,000. Funds will be offered as $20,000 from Lungs for Life and must be matched with equal or greater funding from the applicant’s institution.

Lung Foundation Australia Awards

Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

Cystic Fibrosis Australia Awards

Abbie Fennessy Memorial Fellowship (Sponsored by Technipro-Pulmomed Pty Ltd). More Information [PDF] | Application form [word doc]

The aim of the Fellowship is to improve the knowledge and skills of Allied Health & Nursing professionals working in Cystic Fibrosis care to benefit those who have Cystic Fibrosis. The award provides up to $5000 to support education, training, academic purposes, and/or medical research, activities that improve the quality of medicine and the improvement of Cystic Fibrosis patient outcomes.  The Fellowship is open to Allied Health & Nursing professionals involved in the treatment or care of people with Cystic Fibrosis in Australia.

Watch this space for more award announcements…

icare dust diseases care Scholarships and Fellowships

 

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late May and mid-2017:

The Prince Charles Hospital Foundation Experienced Researcher Project Grants – closes 20/05/17
To support strategic, world-class, sophisticated research on the Foundation’s campus or in significant partnership with this campus in the priority areas of: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

The NVIDIA Foundation Compute the Cure Cancer Research Grants – closes 28/05/17

To advance the fight against cancer. Will fund projects that use computational omics to dramatically impact the battle against cancer and reduce the time it takes for research outcomes to be used effectively in a clinical environment.

The Peer Prize for Women in Science 2017 – closes 31/05/17
This prize is for women researchers across Australia with a mission to accelerate open knowledge exchange and cross-disciplinary innovation.  The are two main areas of research focus: Life Sciences; and Earth, Environmental and Space Sciences. The prize for each category is $20,000.

Australian Institute of Policy and Science – CSL Florey Medal – closes 05/06/17
Award for an Australian biomedical researcher with significant achievements in biomedical science and/or human health advancement for research conducted primarily in Australia. Winners are expected to attend a presentation ceremony in Canberra in November.

Wellcome Trust Pathfinder Awards – closes 20/06/17
The diagnosis, prevention and treatment of orphan and neglected diseases that present an unmet medical need. Seeking to fund pilot studies to develop assets and de-risk future development.

Australian Cancer Research Foundation (ACRF) Cancer Research Grants – closes 23/06/17
Seeks to support all aspects of cancer research and control including but not limited to: cell or molecular biology, epidemiology, early detection, prevention and drug development. Focused on seed funding; primarily providing capital grants for major equipment, and the establishment of capital works and facilities. Collaborative projects between institutions are encouraged.

John T Reid Charitable Trusts – closes 28/06/17
The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

The Sir Robert Menzies Memorial Research Scholarship in the Allied Health Sciences – closes 30/06/17
The purpose of the scholarship is to try to improve the health of Australians by supporting an outstanding applicant from one of the non‐medical allied health disciplines, or from an applicant who is working directly in applied clinical research.

The John Burge Trust – closes 30/06/17
The John Burge Trust was established by the late John Burge to assist people with tuberculosis and support work towards the prevention and cure of the disease. This can include: educational programs for health workers; aid and help for tuberculosis sufferers and who by reason of the disease are disabled; medication; research.

Shepherd Foundation Research Grants – closes 01/07/17 and 15/09/17
For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

GlaxoSmithKline Australia Award for Research Excellence – closes 10/07/17
Recognition for an outstanding researcher with a demonstrated track record of significant work in human medical health, and for whom the award will facilitate career development and further achievements.

The Alan Westcare Project Grant – closes 31/07/17
The Alan King Westcare Project Grant is a 12 month $50,000 grant to available to laboratory, clinical and epidemiological research into the cause, diagnosis, prevention and treatment of respiratory infections such as tuberculosis.

CSL Centenary Fellowships 2017 – closes 31/07/17
To foster excellence in Australian medical research by supporting mid-career Australian scientists to pursue world class medical research. The fellowship provides for a full-time salary (generally equivalent to a Senior Research Fellow C1 level) plus research costs and/or a post-doctoral research assistant. The breakdown is determined by the Fellow, in conjunction with the employing institution at the commencement of the Fellowship. The fellowships are primarily awarded for discovery and translational research with a focus on rare and serious diseases, immunology, and inflammation. However, those who meet the eligibility are strongly encouraged to submit an application for their medical research project.

Centenary Institute Medical Innovation Award 2017 – closes 31/07/17
The Prize focuses on creativity – the essential ingredient in all human endeavour, whether in science, art or marketing. It will be presented to the biomedical research scientist based in Australia who demonstrates the greatest creativity in their scientific approach in a given year. Valued at $36,000.

Government of Western Australia – 2017 Healthway Intervention Research Grants – closing date TBA
Intervention Research Grants will fund applications that demonstrate a clear pathway to a health promotion program or intervention in WA, including policy interventions. Applicants are required to focus on at least one of Healthway’s priority areas of tobacco smoking control, reducing harm from alcohol, good nutrition promotion, physical activity promotion (including reducing sedentary behaviour), mental health promotion, skin cancer prevention, reducing harm from illicit drugs and Aboriginal health. Applications in other areas of health promotion will not be considered.

Rolling Grants

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

 

PhD Scholarships

PhD Scholarship opportunity available at the University of Newcastle: Maternal and early life nutritional status and respiratory health of the offspring.

Please see flyer for more information [PDF]

Applications close 31st July, 2017.

Research Project and Survey Requests

‘Usual’ antenatal asthma management

Dear Colleague,

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study. All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser: https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 

Barriers and Facilitators to Optimal use of Acute Oxygen Therapy in Adults

Dear colleagues,

Our research  team is conducting a study to investigate the  barriers, facilitators and attitudes of health care professionals towards the prescription and delivery of oxygen therapy in the acute care setting. We hope that the results from this study will provide information that will be used to inform and facilitate the translation of evidence based guidelines into clinical practice.

As a clinician who delivers care to patients who use oxygen therapy, we understand that your views and opinions are important. You are invited to participate in this voluntary online survey. It is expected that this should take no longer than 15 minutes. There are no correct or incorrect responses, this survey is designed to explore your opinions regarding acute oxygen therapy.

This study has been granted ethics approval by Hunter New England Human Research Ethics Committee  (Approval number: 16/04/20/5.03) and the University of Newcastle Human Research Ethics Committee (Reference Number: H-2016-0222). For further information you can view the participant information HERE.

There are no anticipated risks to you for taking part in this survey. Information that you provide will be anonymous and remain confidential. Only those directly involved in this research have access to any answers that you provide. Participation in the survey implies consent and can be completed by clicking  the  OXYGEN SURVEY LINK HERE.

Please feel free to contact us directly if you have any questions regarding this research.

We thank you in advance for participating and ask you to consider forwarding this survey to other colleagues, who also deliver care to patients with oxygen therapy.

Kind Regards

Professor Vanessa McDonald
Professor Peter Wark
Joyce Cousins (PhD Scholar)
Contact: joyce.cousins@uon.edu.au

 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.03 – APRIL 2020

VOLUME 2.03 APRIL 2017

Research Roundup:

April 2017

.
 

Welcome Message

Wow, what a conference! I would like to take this opportunity to thank everyone who contributed to making TSANZSRS17 a headline conference. There were many ideas shared and members celebrated. In this Research Roundup we bring to you a full list of the 2017 award winners. But this year of awards is not over yet! Please see below and online at Open Awards to find current opportunities in CF training and research, conference travel, and project support through the Lungs for Life Research Awards. 

Enjoy the April edition of your research roundup.

Prof Phil Hansbro

Chair, Research Sub-Committee

The following articles will take you to thelimbic.com

Aussie research win! The American College of Physicians have highlighted an Australian study as one of the most influential in respiratory medicine from 2016. Read More. 

First-ever pulmonary rehabilitation guidelines for Australia and New Zealand. One key message from the guidelines is that all COPD patients should be offered pulmonary rehabilitation regardless of their disease severity, guideline panel Chair Professor Jennifer Alison told the limbicRead More.

Hidden population at risk of thunderstorm asthma. Many more people than previously thought are at risk of thunderstorm asthma, particularly people who have hay fever, a survey reveals. Read More.

Doctor deaths prompt further investigation. NSW Health Minister Brad Hazzard has asked his department to report back within four weeks with advice on how to make hospitals a safer workplace for junior doctors. Read More. 

Respiratory nurses agree they have a role in advance care planning. But tension still exists about how and when to initiate conversations with patients, Dr Rebecca Disler told conference delegates. Read More. 

Short on drug options for shortness of breath. Morphine is still the best pharmacological treatment for chronic breathlessness, according to an extensive review of the literature. Read More.

GPs too passive in approach to COPD. GPs hold back on formerly diagnosing people with COPD and delay offering interventions such as smoking cessation or pulmonary rehabilitation, a survey shows. Read More.

New hope for people with IPF. Evidence is building for the non-pharmacological management of idiopathic pulmonary fibrosis including ambulatory oxygen and pulmonary rehabilitation, Professor Anne Holland told the conference this afternoon during a plenary session on novel therapies in IPF. Read More. 

2017 Award Winners

Presented at the 2017 TSANZ ASM in Canberra

Thoracic Society Medals

Laennec Medal – presented to the outgoing TSANZ President, Prof Peter Gibson

Society Medal – presented to A/Prof Peter Holmes

50th Anniversary Medal – presented to Prof Jennifer Alison and Prof Richard Ruffin

President’s Award – presented to Dr Becky Freeman

Wunderly Oration – delivered by Prof Jennifer Martin

Fellowships

TSANZ / National Asthma Council Australia – Asthma and Airways Career Development Fellowship – presented to Dr Adam Collison

2016 Vertex Adult Cystic Fibrosis  Fellowship – presented to Dr Anna Tai

Lung Foundation Australia / Boehringer Ingelheim COPD Research Fellowship 2017/2018 – presented to Dr Anna Hudson

Abstract-linked Awards

TSANZ Janet Elder Early Career Travel Awards – presented to Dr Luke Garratt and Dr Jade Jaffar

TSANZ Janet Elder Mid Career Travel Award – presented to Prof Lisa Wood

TSANZ / Japanese Respiratory Society Early Career Travel Award – presented to Dr Eugene Roscioli

TSANZ / Boehringer Ingelheim COPD Travel Award – presented to Dr Eskandarain Shaffudin

Ann Woolcock New Investigator Finalists

Tim Rosenow, Telethon Kids, University of Western Australia
Simone Barry, Royal Adelaide Hospital
Eugene Roscioli, Royal Adelaide Hospital, Lung Research Laboratory
Thomas Iosifidis, University of Western Australia [Winner]
Rhiannon Werder, University of Queensland
Phillipa Southwell, Charles Sturt University

Research Project Support Awards

2016 Boehringer Ingelheim COPD Research Award – presented to A/Prof Greg Hodge and Prof Sandra Hodge

2017 Boehringer Ingelheim COPD Research Award – presented to Dr Maria Sukkar and Dr Jane Bourke

Maurice Blackburn Grant-in-Aid for Asbestos Research – presented to Prof Steve Mutsaers

AstraZeneca Grant-in-Aid for Severe Asthma – presented to Dr Fatemeh Moheimani

TSANZ Robert Pierce Grant-in-Aid for Indigenous Lung Health – presented to Dr Holly Clifford

Lung Foundation Australia / Ivan Cash Research Grant-in-Aid Award – presented to Dr Yet Hong Khor

Lung Foundation Australia / Lizotte Family Research Award – presented to Dr Michael Schuliga

Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research – presented to Prof Peter Middleton

Australian Cystic Fibrosis Research Trust 2017 Innovation Grant – presented to Dr Jay Horvat, Prof Peter Wark, and Prof Phil Hansbro

Travel Awards

TSANZ Peter Phelan Travel Fellowship – presented to Dr Kimberley Wang

TSANZ Respiratory Nurse Career Development Award for Indigenous Research – presented to Ms Erin Plumb

Special Interest Group Awards

  • TSANZ Best Poster Prize (supported by Boehringer Ingelheim) – presented to David Chapman
  • Asthma & Allergy (supported by National Asthma Council Australia) – presented to Joy Lee
  • Asthma & Allergy (supported by Asthma Australia) – presented to James Pinkerton
  • OELD/Population Health (supported by Maurice Blackburn ) – presented to Holly Clifford
  • Lung Cancer (supported by Maurice Blackburn) – presented to Koliarne Tong
  • COPD (supported by Boehringer Ingelheim) – presented to Steven Maltby
  • OLIV (supported by Boehringer Ingelheim) – presented to Rebecca Harper
  • Primary Care (supported by Boehringer Ingelheim) – presented to Juliet Foster
  • Respiratory Nurses Oral (supported by Boehringer Ingelheim) – to co-presenters Mary Roberts and Vinita Swami
  • Pulmonary Physiology and Sleep, John Reid Prize (supported by Lung Foundation Australia) – presented to Mahesh Dharmakamara
  • David Serisier Memorial Award 2016 for Translational Research – Respiratory Infectious Disease (supported by Lung Foundation Australia) – presented to Su-Ling Loo
  • Cystic Fibrosis (Supported by Cystic Fibrosis Australia) – presented to Michelle Wood
  • Cell biology/Immunology – Andrew Reid
  • Evidence Based Medicine – presented to Narelle Cox
  • Interventional Pulmonology – presented to Arash Badiei
  • Peter van Asperen Paediatric Award – presented to Ajay Kevat
  • Physiotherapy – presented to Sally Wootton
  • Tobacco Control – presented to Jenifer Liang

Open Awards

Vertex Awards

Vertex Paediatric Cystic Fibrosis Clinical Fellowship

The TSANZ Vertex Cystic Fibrosis Paediatric Clinical Fellowship supports an articulated training program for advanced trainees who are currently, or who wish to sub-specialize in Paediatric Respiratory Medicine, specifically to conduct the research, diagnosis and management of cystic fibrosis in Australia and New Zealand.

This is a unique opportunity to secure a fellowship that supports clinic based training in a Paediatric specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Adult Cystic Fibrosis Fellowship

The TSANZ Vertex Adult Cystic Fibrosis Fellowship will support a health practitioner or research scientist working in respiratory medicine who wishes to undertake research into adult cystic fibrosis, accompanied with professional development in adult cystic fibrosis in Australia or New Zealand.

This is a unique opportunity to secure a fellowship that supports either research and/or clinic based training / professional development in the adult cystic fibrosis specialty area.

The fellowship shall be to the value of AUD$50,000 per annum for two years.

Vertex Cystic Fibrosis Research Awards

To foster ongoing original cystic fibrosis research and its communication internationally.

The winners of the awards (2) will receive an award up to the value of AUD$7500 each to support their economy class travel, registration and accommodation to present their research at the European Cystic Fibrosis Society Annual Meeting or the North American Cystic Fibrosis Conference.

Lungs for Life Awards

Lungs for Life Research Awards

This Research Award aims to provide seed funding for critical and impactful areas of respiratory research. Preference will be given to research proposals in the priorities areas of early lung development, infection, and lung cancer. Three research proposals will be funded.

The Research Award value will total $40,000. Funds will be offered as $20,000 from Lungs for Life and must be matched with equal or greater funding from the applicant’s institution.

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards

Lung Foundation Australia and A Menarini Australia Pty Ltd are excited to announce that there will be six (6) Travel Grants of up to $3,000 for international conferences and up to $1,500 for national conferences on offer to health professionals/researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

Watch this space for more award announcements…

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late April and mid-2017:

Association for International Cancer Research Grants – 21/04/17
Project grants of between one and three years to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. Proposals in which a mixture of basic and clinical research is proposed will be considered.

The Rebecca L. Cooper Medical Research Foundation Al and Val Rosenstrauss Medical Research Fellowship – closes 28/04/17
The Al and Val Rosenstrauss Research Fellowships are named in honour of the late Al Rosenstrauss OAM and his wife, Val, for their contribution to the work of the Foundation over a period of more than 28 years. Research project must be in one of the nominated areas of medical research that are supported by the Foundation; Brain Sciences, Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, and Vision Sciences. Applicants who have received previous funding, or worked in a laboratory supported by the Foundation, will be favoured.

The Bioinformatics Peer Prize – closes 30/04/17
In partnership with the Centre for Systems Genomics at the University of Melbourne, The Australian Regenerative Medicine Institute at Monash University & Melbourne Bioinformatics, Thinkable is excited to launch the inaugural ‘Peer Prize’ for bioinformatics. The objective is to accelerate wider knowledge exchange & drive multi-disciplinary collaboration with the latest bioinformatics research from around the world, while celebrating the most exciting new discoveries made in the field as voted by peers.

Sylvia and Charles Viertel Charitable Foundation Clinical Investigatorships – closes 30/04/17
To stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment.

Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship – closes 30/04/17
Providing salary and project grant support for outstanding medical researchers.

Bill & Melinda Gates Foundation Grand Challenges Explorations Round 19 – closes 11/05/17
Early-stage innovative research projects from a range of disciplines and regions.

Winston Churchill Memorial Trust Fellowship – closes 15/05/17
To provide an opportunity for Australians to travel overseas (for 4 – 6 weeks) to conduct research in their chosen field that is not readily available in Australia.

The Prince Charles Hospital Foundation Experienced Researcher Project Grants – closes 20/05/17
To support strategic, world-class, sophisticated research on the Foundation’s campus or in significant partnership with this campus in the priority areas of: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

Australian Institute of Policy and Science – CSL Florey Medal – closes 28/05/17
Award for an Australian biomedical researcher with significant achievements in biomedical science and/or human health advancement for research conducted primarily in Australia. Winners are expected to attend a presentation ceremony in Canberra in November.

The NVIDIA Foundation Compute the Cure Cancer Research Grants – closes 28/05/17
To advance the fight against cancer. Will fund projects that use computational omics to dramatically impact the battle against cancer and reduce the time it takes for research outcomes to be used effectively in a clinical environment.

Australian Institute of Policy and Science – CSL Young Florey Medal – closes 06/06/17
Award for an Australian biomedical researcher with significant early career achievements in biomedical science and/or human health advancement. Selection Criteria: Excellence in research achievement in the biomedical science and/or human health advancement; and Excellence and passion in communication and community engagement to promote understanding and engagement in science.

Wellcome Trust Pathfinder Awards – closes 20/06/17
The diagnosis, prevention and treatment of orphan and neglected diseases that present an unmet medical need. Seeking to fund pilot studies to develop assets and de-risk future development.

Australian Cancer Research Foundation (ACRF) Cancer Research Grants – closes 23/06/17
Seeks to support all aspects of cancer research and control including but not limited to: cell or molecular biology, epidemiology, early detection, prevention and drug development. Focused on seed funding; primarily providing capital grants for major equipment, and the establishment of capital works and facilities. Collaborative projects between institutions are encouraged.

John T Reid Charitable Trusts – closes 28/06/17
The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

The Sir Robert Menzies Memorial Research Scholarship in the Allied Health Sciences – closes 30/06/17
The purpose of the scholarship is to try to improve the health of Australians by supporting an outstanding applicant from one of the non‐medical allied health disciplines, or from an applicant who is working directly in applied clinical research.

The John Burge Trust – closes 30/06/17
The John Burge Trust was established by the late John Burge to assist people with tuberculosis and support work towards the prevention and cure of the disease. This can include: educational programs for health workers; aid and help for tuberculosis sufferers and who by reason of the disease are disabled; medication; research.

Shepherd Foundation Research Grants – closes 01/07/17 and 15/09/17
For research projects in all aspects of preventative medicine and/or occupational medicine. Applicants may apply for funding of one, two or three years.

Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

The Alan Westcare Project Grant – closes 31/07/17
The Alan King Westcare Project Grant is a 12 month $50,000 grant to available to laboratory, clinical and epidemiological research into the cause, diagnosis, prevention and treatment of respiratory infections such as tuberculosis.

CSL Centenary Fellowships 2017 – closes 31/07/17
To foster excellence in Australian medical research by supporting mid-career Australian scientists to pursue world class medical research. The fellowship provides for a full-time salary (generally equivalent to a Senior Research Fellow C1 level) plus research costs and/or a post-doctoral research assistant. The breakdown is determined by the Fellow, in conjunction with the employing institution at the commencement of the Fellowship. The fellowships are primarily awarded for discovery and translational research with a focus on rare and serious diseases, immunology, and inflammation. However, those who meet the eligibility are strongly encouraged to submit an application for their medical research project.

Government of Western Australia – 2017 Healthway Intervention Research Grants – closing date TBA
Intervention Research Grants will fund applications that demonstrate a clear pathway to a health promotion program or intervention in WA, including policy interventions. Applicants are required to focus on at least one of Healthway’s priority areas of tobacco smoking control, reducing harm from alcohol, good nutrition promotion, physical activity promotion (including reducing sedentary behaviour), mental health promotion, skin cancer prevention, reducing harm from illicit drugs and Aboriginal health. Applications in other areas of health promotion will not be considered.

Rolling Grants

Advance Queensland Founders’ Fellowships – closes 12/05/17 (quarter one round)
To support entrepreneurial scientists, researchers and clinicians to take 12 months away from their normal job to develop their early stage novel and innovative ideas with commercialisation prospects into new products, processes or services.

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

 

Respirology

Respirology Issue 22.3

Association between asthma control and asthma cost: Results from a longitudinal study in a primary care setting

By Nguyen et al. (resp.12930/ RES-16-407.R2)

 

Singhealth Duke-NUS Research team members from Canada and Singapore. Left to right:Lye Weng Kit, Dr Ngiap C. Tan, Dr. Nivedita V. Nadkarni, Usha Sankari, Dr Hai V. Nguyen and Shweta Mital.

 

YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia

By Spoorenberg et al. (resp12924/RES-16-449.R1)

 

CAP study group members from St Antonius Hospital in Nieuwegein, The Netherlands.

Left to right: Willem Jan Bos, Simone Spoorenberg, Stefan Vestjens and Jan Grutters.

 

Respirology Issue 22.4

Home-based telerehabilitation via real-time videoconferencing improves endurance exercise capacity in patients with COPD: The randomized controlled TeleR Study

LING LING Y. TSAI, RENAE J. MCNAMARA, CHLOE MODDEL, JENNIFER A. ALISON, DAVID K. MCKENZIE AND ZOE J. MCKEOUGH   

(DOI: 10.1111/resp.12966)

 

The respiratory telerehabilitation (TeleR) trial team from Sydney, Australia

 

Nasal lavage, blood or sputum: Which is best for phenotyping asthma?

CAMYLA F. DE FARIAS, MARIA M.F. AMORIM, MICHEL DRACOULAKIS, LILIAN B. CAETANO, ILKA L. SANTORO AND ANA L.G. FERNANDES

(DOI: 10.1111/resp.12958)

 

The Asthma Group EPM-Unifesp from São Paulo, Brazil. Left to right: Danilla Assad Fernandes, Lilian Ballini Caetano, Michel Dracoulakis, Patricia Bueno Fernandes, Fabiana Stanzani, Camyla Fernandes, Maria Amélia Carvalho Santos, Ana Luisa Godoy Fernandes, Maria Marta Amorim.

Australasian Clinical Tuberculosis Network (ACTnet)

The Australasian Clinical Tuberculosis Network (ACTnet) is a collaborative clinical research group spanning Australia and New Zealand. Following the successful model of the European “TBnet” collaboration (www.tb-net.org), ACTnet will engage clinicians and researchers across the two countries to conduct high-quality research of national and international significance. It will provide a platform for individual investigators, within infectious disease, respiratory, public health and other disciplines, to propose and implement multi-centre studies and laboratory collaborations.

ACTnet aims to promote basic science, clinical and public health research into TB in Australia and New Zealand. We will be working in partnership to create the knowledge required to eliminate TB in Australia, New Zealand and beyond.

We are inviting TSANZ members to join our network. There are a variety of ways you can contribute to the growth of this network but becoming a member is the first step.  Please see our website www.actnet.org.au  further details and if interested click on the ‘Become a member’ sign up box on the home page.

Alternatively you can send an email to elyse.guevara-rattray@sydney.edu.au the ACTnet Network Officer. ACTnet is supported by ARC, TSANZ, ASID and TBForum.

Research Project and Survey Requests 

Recruiting for new study investigating the effects of ambulatory oxygen therapy via portable concentrator in interstitial lung disease

Researchers at Austin Health are currently recruiting patients with chronic interstitial lung disease and exertional desaturation (< 90% on room air during the 6-minute walk test) for a randomized controlled trial investigating the effects of ambulatory oxygen therapy via portable concentrators. Inclusion and exclusion criteria are in the link below. 

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371748&isReview=true  

If you wish to discuss possible patients for screening and enrolment or receive further information, please contact Yet Hong Khor on 03 9496 5390 or YetHong.Khor@austin.org.au.

This study has been approved by the Austin Health Human Research Ethics Committee.

 

Are you interested in helping us further our understanding of healthcare professionals’ perceptions of asthma using an innovative method – drawings?

If so, and you are a healthcare professional, you are invited to take part in a research study exploring the use of drawings to further understanding of healthcare professionals’ perceptions of the experience of asthma.

An emerging approach for investigating people’s perspectives of illness is the use of drawings. Despite the high prevalence of asthma, there is yet to be research using drawing to explore healthcare professionals’ perceptions of the experience of asthma in the Australian population. Drawings may be useful for expression and could increase our understanding of the perspective of healthcare professionals involved in asthma management. The total time commitment is expected to be approximately one hour. You will be reimbursed for your time.

If you would like more details or would like to take part, please contact the researchers (details below). Thank you!

A/Prof Lorraine Smith, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9036 7079

Melissa Cheung, PhD Candidate, Faculty of Pharmacy, The University of Sydney
Email: lorraine.smith@sydney.edu.au Telephone: 02 9351 3710

 

Paediatric PFT needs assessment

We are undertaking a project to assess and address the needs of the global paediatric pulmonology/respirology community for practice guidelines for paediatric pulmonary function testing in both the clinical and research settings.

The first step in this project is to define and understand those needs via a short (less than 5 minute) survey. We ask that you complete this brief survey to help us understand how to best meet the needs of our community. Please click on the link below to complete the survey online.

Survey

Thank you for your time.

Nitin Kapur, Paediatric SIG Convenor

on behalf of 

Members of the American Thoracic Society/European Respiratory Society Infant & Preschool Pulmonary Function Testing Working Group and the European Respiratory Society Pediatric Respiratory and Sleep Physiology Working Group:

Graham Hall, BSc PhD
Jessica Pittman, MD MPH
Padmaja Subbarao, MD MSc FRCP
Claudia Calogero, MD
Stephanie Davis, MD
Margaret Rosenfeld, MD MPH

 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.03 – APRIL 2020

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 5.03 – APRIL 2020

VOLUME 5.04 – JUNE 2020

Research Roundup:

June 2020

 

Welcome Message

Welcome to this exciting update of the Research Roundup.

Many of you would have experienced the success of our first virtual Ann Woolcock Award presentation session. I congratulate all the finalists for adapting so well to this new format and to the audience who quickly settled into the Zoom Q&A system and challenged the speakers with stimulating questions.

The RSC members are having a well-earned break from their arduous but rewarding grant review duties, and both I and the Society sincerely thank these members for all their hard work. Their break will be short as awards will open again in the coming months.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the June edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

2020 Respiratory Research Excellence Awards

 

TSANZ congratulates the following award winners!!!

 

Ann Woolcock New Investigator Award Winner: Kurtis Budden

Ann Woolcock New Investigator Award Finalists: Kak-Ming Ling, Rebecca Stockwell, Steven Taylor, Pamela Laird, Razia Zakarya

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship: Simon Craig

TSANZ/AstraZeneca Respiratory Research Mid-Career Fellowship: Hayley Scott

TSANZ/AstraZeneca Respiratory Research Early Career Fellowship: Steven Taylor

Australian Cystic Fibrosis Research Trust 2020 Innovation Grant: Abdullah Tarique, Peter Sly, Emmanuelle Fantino, Clair Wainwright, and Scott Bell

Vertex Adult Cystic Fibrosis Research Award: Sandra Hodge, Peter Zalewski, David Parsons, Andrew Tai, Sally Chapman, Judith Morton, and Emily Hopkins

Vertex Paediatric Cystic Fibrosis Research Award: Shafagh Waters and Adam Jaffe

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease: Mariane T Turner, Samuel Sameh, Robert A Cohen, and Deborah H Yates           

TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health: Kristin Carson-Chahhoud

TSANZ Peter Phelan Paediatric Research Award: Shivanthan Shanthikumar

TSANZ / Boehringer Ingelheim Australia COPD Travel Award: Katrina Tonga

TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award: Hajar Ali

TSANZ/JRS Early Career Development Award: Saleela Ruwanpura

Janet Elder International Mid-Career Travel Award: David G Chapman

Janet Elder International Early Career Travel Award Recipient 1: Steven Taylor

Janet Elder International Early Career Travel Award Recipient 2: Tony Zhang

TSANZ Respiratory Nurses Career Development Award for Indigenous Research:Kobi Schutz

 

TSANZ would like to thank our partners and sponsors for their support of excellent respiratory research and researchers!

2020 TSANZ Awards by Nomination

At TSANZ 2020 AGM we recognised seven leaders in their field of lung health.

TSANZ 50th Anniversary Medal for Education and Training – Associate Professor David Fielding.

The 50th Anniversary Medal is awarded each year in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand.

TSANZ Research Medal – Professor Shyamali Dharmage, Professor Alan James

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand. This year, due to the calibre of nominations, the TSANZ Board has chosen two recipients for the TSANZ Research Medal.

TSANZ Society Medal – Associate Professor Tara Mackenzie

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand.

Fellowships

  • Professor Richard Beasley
  • Professor Margaret Wilsher
  • Professor Ross Vlahos

Each year the TSANZ board considers peer nominations for Fellow status of the Thoracic Society of Australia and New Zealand (TSANZ). Fellow status is awarded to members who have demonstrated exceptional contributions to the field of respiratory health in Australia or New Zealand.

Congratulations to all!

Respirology – Editor’s Choice 

Respirology Issue 25.5 May 2020

 

Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis

Na Wu, Changjiang Xue, Shiwen Yu and Qiao Ye

 

Chest HRCT of 2 peatients with natural stone-associated findings (top) and 2 patients with artificial stone-associated silicosis (Bottom)

DOI: 10.1111/resp.13744

 

Acute exacerbations of fibrotic interstitial lung diseases

Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara, Masahiko Ando, Tomonori Tanaka, Naozumi Hashimoto, Koji Sakamoto and Yoshinori Hasegawa

 

Researchers from the ILD collaborative team from Japan and US. From left to right: (front) Dr. Yasuhiro Kondoh, Dr. Kevin K. Brown, Dr. Yoshinori Hasegawa; (back) Dr. Atsushi Suzuki, Dr. Koji Sakamoto, Dr. Naozumi Hashimoto, Dr. Kensuke Kataoka, Dr. Yuji Saito.

DOI: 10.1111/resp.13682

Respirology Issue 25.6 June 2020

 

Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

Miranda P. Ween, Rhys Hamon, Matthew G, Macowan, Leigh Thredgold, Paul R. Reynolds and Sandra J. Hodge

 

A collection of e-cigarettes and e-liquids for sale to vapers

DOI: 10.1111/resp.13696

 

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte and Harold R. Collard

 

 

The research team from the University of California San Francisco in the United States (c269928 represents Brett Ley)

DOI: 10.1111/resp.13753

TSANZSRS 2020 Abstracts

Due to the COVID-19 pandemic, the TSANZSRS 2020 ASM has been postponed until 30 April – 4 May 2021. This supplement contains Abstracts that were accepted for presentation at the 2020 meeting.

Volume 25, Issue S1 TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 27–31 March 202

 

Invitations and surveys

 

CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

Dear Members of the Thoracic Society of Australia and New Zealand,

Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

https://www.surveymonkey.com/r/F38Q8K2

We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

 

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

Dear Colleagues,

We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

Caring for People with Intellectual Disability survey

Thank you for considering our invitation
A/Prof Nathan Wilson, Western Sydney University
Dr Peter Lewis, Western Sydney University
Ms Virginia Howie, Central Queensland University
Dr Melissa Desroches, University of Massachusetts, Dartmouth

Kind regards,
Virginia

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

 

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland
Professor of Physiotherapy, Monash University and Alfred Health
Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

.

 

VOLUME 5.03 – APRIL 2020

VOLUME 5.02 – MARCH 2020

Research Roundup:

March 2020

.

Welcome Message

By now I’m sure you’ve heard that TSANZSRS 2020 has been postponed until 29 April – 4 May 2021. The TSANZ Board released a letter and FAQ outlining this decision on 12 March 2020.

The Board is busy working through all the issues that have arisen from this decision and we will be in touch with updates as they happen. Whilst the the Research Sub-Committee has finalised most awards, we are now looking at how to publicly acknowledge 2020 award recipients. 

COVID-19

Infectious diseases research is a significant area of strength in Australia and the TSANZ acknowledges the important work of our Australian researchers who are international leaders in research surrounding COVID-19. Examples include the creation of the vaccine candidate for COVID-19 by the University of Queensland – achieved in just three weeks! Scientists at CSIRO’s state-of-the-art biologics production facility in Melbourne have already begun small-scale testing. Doherty Institute researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection (published in Nature) while CSIRO’s research aims to get a better understanding of the virus – how long it takes to develop and replicate, how it impacts the respiratory system and how it can be transmitted. 

We also acknowledge the support of the Australian Government that will invest $30 million for COVID-19 research to enable Australian researchers to contribute to global efforts to control the outbreak. In addition, NHMRC recognises that the COVID-19 pandemic may be affecting the research of current grant holders. If you have received a grant and circumstances have changed – for example, there has been a delay in your Research Activity because of involvement in the clinical or public health response – you can apply to vary your grant. Variations that may be relevant due to the impact of COVID-19 include: Deferral of commencement date and requests for grants applications, deferral of an in-progress grant and extended leave requests, extended end date, change to a research plan or change to chief investigators. For more information please visit: https://www.nhmrc.gov.au/funding/manage-your-funding/vary-your-grant.

TSANZ are collaborating to support the Australian Living Evidence Consortium who, with Cochrane Australia are working to develop a National COVID-19 Clinical Evidence Taskforce. There is a survey below which will help to determine high-priority clinical questions and a request for EOIs to join the guideline panel. I encourage all interested parties to contribute to this work through the article below.

We wish you all the best in your work and in preparation of your grant applications.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

National COVID-19 Clinical Evidence Taskforce

Dear colleague,

The Australian Living Evidence Consortium and Cochrane Australia are working with others to support the development of a National COVID-19 Clinical Evidence Taskforce. As part of this we are working with peak professional bodies to develop living, evidence-informed guidance for primary, hospital and critical care of adults and children with suspected or confirmed COVID-19 infection. Guidance will be updated weekly as new evidence emerges.

We would like your suggestions for high-priority clinical questions to be addressed by this guidance.

Please suggest questions by completing the form at https://forms.gle/SDS9t2tMhiHvnRoPA by 9pm Sunday March 22.

We are also seeking interested clinicians to join guideline panels. These will initially be convened next week, and then meet regularly over the next weeks and months to review emerging evidence and refine the recommendations. To express your interest in membership in a guideline panel, please email your CV to Dr Britta Tendal, Senior Research Fellow at Cochrane Australia at britta.tendal@monash.edu by 9pm Sunday March 22. 

If you have any queries please contact Dr Tari Turner, Senior Research Fellow at Cochrane Australia at tari.turner@monash.edu

Thank you

Respirology – Editor’s Choice 

Respirology Issue 25.3 March 2020

 

Global Lung Function Initiative‐2012 ‘other/mixed’ spirometry reference equation provides the best overall fit for Australian Aboriginal and/or Torres Strait Islander children and young adults

Tamara L. Blake, Anne B. Chang, Mark D. Chatfield, Julie M. Marchant and Margaret S. McElrea

 

DOI: 10.1111/resp.13649

Study participant from Thursday Island performing spirometry (with permission by the Queensland Government)

 

Association of serious adverse events with Cheyne–Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis

Faizan Javed, Renaud Tamisier, Jean-Louis Pepin, Martin R. Cowie, Karl Wegscheider, Christiane Angermann, Marie-Pia D’ortho, Erland Erdmann, Anita K. Simonds, Virend K. Somers, Helmut Teschler, Patrick Levy, Jeff Armitstead and Holger Woehrle

 

 Schematic representation of CheyneStokes respiration signal.

DOI: 10.1111/resp.13613

Invitation

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland

Professor of Physiotherapy, Monash University and Alfred Health

Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University

Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X